FierceBiotech | GlaxoSmithKline and J&J back a $100M new Alzheimer's R&D project FierceBiotech GlaxoSmithKline ($GSK), Johnson & Johnson ($JNJ) and a group of industry titans are helping kick off a U.K. government-led fund designed to spotlight new approaches to dementia and Alzheimer's disease, investing in a $100 million effort to bankroll ... UK, Drugmakers Establish $100M Alzheimer's Venture Fund Alzheimer Society Part of Global Action Against Dementia |